Cohort Study of Patients With Type 1 Diabetes Registered With Mobile Application in China

Cohort Study of Patients With Type 1 Diabetes Registered With Mobile Application in China

For last decade, the innovation of mobile health platform has brought new opportunities for disease management. Previous studies have shown that health management programs based on mobile platforms for patients with diabetes can improve patients' glucose control, self-management ability and quality of life. Type 1 diabetes mellitus (T1DM) due to its characteristics needs long-term linkage care throughout the lifespan cycle of patients. Therefore, this study intends to construct a prospective and open T1DM cohort based on mobile application and platform, to deliver home-community-hospital joint management for patients, and to provide follow-up online or offline every 3 months lasting for 10 years. Mainly, the objective of this study is to observe the blood glucose control outcome of T1DM patients. Secondly, the control of comprehensive metabolic indicators such as blood pressure and blood lipid, occurrence and progression of acute and chronic complications, and psychosocial status were included as well, expecting to provide scientific evidence for continuously improving the quality of T1DM management.

Inclusion Criteria:

• At least 12 years old;
• Diagnosed as type 1 diabetes according to World Health Organization (WHO) criteria in 1999;
• Be able to use smart mobile phones;
• Informed consent and voluntary participation.

Exclusion Criteria:

• Secondary diabetes;
• Complicated with malignant diseases, such as cancer, hepatic and renal failure;
• Complicated with cognitive impairment or mental illness;
• Be pregnant or lactating at the time of enrollment.